A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors

Name: A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors
Published: 2020
License: Public Domain

Pfizer · 2020

ClinicalTrials.gov · Datasets · License: Public Domain · 2020

Open Source ↗

breast-cancer colorectal-cancer nsclc ovarian-cancer pancreatic-cancer prostate-cancer

advanced solid tumors, solid tumors, ovarian cancer, breast cancer, prostate cancer, nsclc, pancreatic cancer, colorectal cancer, parp inhibitor, talazoparib, talzenna, brca mutation

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 863287
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.